TMCnet News
Research and Markets: Global Analysis of Ebola Disease: First-of-its-Kind Analysis of Market Sizing and Revenue Forecasts through 2016DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/vllsjj/global_analysis) has announced the addition of the "Global Analysis of Ebola Disease" report to their offering. This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll nearing 5,000. The Ebola market is segmented by diagnostics and pharmaceuticals, and the diagnostics market includes both molecular methods and immunodiagnostics tests, of which a 2-year potential-revnue forecast is provided. Molecular methods will see wide adoption for the specificity, sensitivity, and rapidity of the tests. Competitive landscape and companies to watch chapters are provided. Key Findings:
Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Landscape 4. Companies to Watch 5. Our Story For more information visit http://www.researchandmarkets.com/research/vllsjj/global_analysis
|